Erythromelalgia precipitated by acral erythema in the setting of thrombocytopenia

Journal of the American Academy of Dermatology

Volumn 48, Issue 6, 2003, Pages 973-975

  Coppa, Lisa M ^a   Nehal, Kishwer S ^b   Young, James W ^b   Halpern, Allan C ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; STEROID; THIOTEPA;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BURNING SENSATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHIARI FROMMEL SYNDROME; CLINICAL FEATURE; ERYTHEMA; ERYTHROMELALGIA; FEMALE; FOLLOW UP; HEADACHE AND FACIAL PAIN; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SYMPTOM; THROMBOCYTOPENIA;

EID: 0038115691     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.304     Document Type: Article

References (10)

1. Kalgaard OM, Seem E, Kvernebo K. Erythromelalgia: a clinical study of 87 cases. J Intern Med 1997;242:191-7.
2. Babb RR, Alarcon-Segovia D, Fairbairn JF II. Erythermalgia: review of 51 cases. Circulation 1964;29:131-41.
3. Boneu B, Pris J, Guirard B, Boneu A, Auvergnat A, Corberand J, et al. [Abnormalities of platelet aggregation during essential thrombocythemia: effects of aspirin on erythromelalgia]. Nouv Presse Med 1972;36:2383-8. French.
4. Mork C, Asker CL, Salerud EG, Kvernebo K. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol 2000;114:643-6.
5. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 2000;43:841-7.
6. Michiels JJ, Abels J, Steketee J, van Vliet VD, Abels J. Erythromelalgia caused by platelet mediated arteriolar inflammation in thrombocythemia. Ann Intern Med 1985;102:466-71.
7. Davis MDP, O'Fallon WM, Rogers RS III, Rooke TW. Natural history of erythromelalgia. Arch Dermatol 2000;136:330-6.
8. Kurzrock R, Cohen PR. Erythromelalgia: review of clinical characteristics and pathophysiology. Am J Med 1991;91:416-22.
9. Kurzrock R, Cohen PR. Erythromelalgia and myeloproliferative disorders. Arch Intern Med 1989;149:105-9.
10. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999;40:367-98.